Chantal Etiévant

1.0k citations
34 papers · 872 indexed · h-index 18
Topics
Cancer therapeutics and mechanisms (12 papers)Cancer Treatment and Pharmacology (8 papers)Microtubule and mitosis dynamics (6 papers)

In The Last Decade

Chantal Etiévant

33 papers receiving 851 citations

Peers

Chantal Etiévant
Comparison fields: 5 of 82
  • Molecular Biology 596
  • Oncology 341
  • Cell Biology 144
  • Organic Chemistry 129
  • Cancer Research 83
Replace B H Long with:
B H Long United States
Jean‐Marc Barret France
Mariagrazia Distefano Italy
Melvin J. Yu United States
Bulbul Pandit United States
Yongxia Zhu China
Manuel Luís Orta Spain
Zhengduo Yang China
Katsushige Gomi Japan
Donghwa Kim South Korea
Chantal Etiévant relative to B H Long United States B H Long's profile →
Citations per field
00.5×1.5×2.1×
B H Long · 1×
Citations per year

Countries citing papers authored by Chantal Etiévant

Since Specialization
Citations

This map shows the geographic impact of Chantal Etiévant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chantal Etiévant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chantal Etiévant more than expected).

Fields of papers citing papers by Chantal Etiévant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chantal Etiévant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chantal Etiévant. The network helps show where Chantal Etiévant may publish in the future.

Co-authorship network of co-authors of Chantal Etiévant

This figure shows the co-authorship network connecting the top 25 collaborators of Chantal Etiévant. A scholar is included among the top collaborators of Chantal Etiévant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chantal Etiévant. Chantal Etiévant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 83
3 9
4 19
5 51
6 6
7 7
8 8
9 33
10 24
11 14
12 43
13 17
14 17
15 77
16 13
17 62
18 13
19 24
20 0

About Chantal Etiévant

Chantal Etiévant is a scholar working on Oncology, Cell Biology and Biophysics, having authored 34 papers that have together received 872 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (12 papers), Cancer Treatment and Pharmacology (8 papers) and Microtubule and mitosis dynamics (6 papers). The work is most often cited by research in Toxicology (70 citations), Oncology (341 citations) and Cell Biology (144 citations). Chantal Etiévant has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Anna Kruczynski, Bridget T. Hill, Jean‐Marc Barret, Dominique Perrin, Jacques Fahy, Paola B. Arimondo, Dany Pechalrieu, Françis C. Colpaert, Thierry Imbert and B van Hille. Their work appears in journals such as Biochemistry, Oncogene and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026